Any claim that spending on the PBS is stagnant belies $3.3 billion in topline growth, representing the program's single biggest year-on-year financial expansion in its 75-year history, $7 billion in new listings over 18 months, Budget rules and the impact of the industry's agreements with the federal government.
Far from 'stagnating', the PBS has delivered record growth as it rapidly approaches $20 billion
May 10, 2023 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
FDA invites submissions to new rapid review priority program
July 25, 2025 - - Latest News -
Pharmac marks 12-month anniversary of funding boost
July 25, 2025 - - Latest News -
AccessCR announces finalists in Consumer Partnerships in Research Awards
July 24, 2025 - - Latest News -
Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close
July 24, 2025 - - Australian Biotech -
Australia on the list of countries to be targeted over pharmaceutical pricing
July 24, 2025 - - Latest News -
Latest trade agreements reveal US focus on resolving longstanding issues
July 24, 2025 - - Latest News -
Sanofi to acquire Vicebio, gaining rights to Queensland discovered technology
July 23, 2025 - - Australian Biotech